PNV 3.29% $2.35 polynovo limited

broker recommendation, page-133

  1. 1,842 Posts.
    lightbulb Created with Sketch. 366
    The CEO has indicated a goal of servicing 1 million patients per year.

    And this doesn't come from idle speculation but deep experience of medtech markets and an understanding of how remarkable PolyNovo's tech is.
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.